Summary: Axsome Therapeutics In. is set to present multiple studies on AXS-12 and solriamfetol at Sleep Europe 2024, the 27th Congress of the European Sleep Research Society. These presentations include topline results from the phase 3 SYMPHONY trial of AXS-12 for narcolepsy, … [Read more...]
Zevra to Present Phase 2 Data on KP1077 for Idiopathic Hypersomnia
Summary: Zevra Therapeutics announced that Rene Braeckman, PhD, the company’s senior vice president of clinical development, will present top-line data from the phase 2 clinical trial of KP1077 (serdexmethylphenidate) in patients with idiopathic hypersomnia (IH) at Sleep Europe … [Read more...]
Alkermes to Present Data on ALKS 2680 for Narcolepsy Type 2 and Idiopathic Hypersomnia
Summary: Alkermes plc is set to present data from its phase 1b study of ALKS 2680, a novel oral orexin 2 receptor agonist, at Sleep Europe 2024. The study evaluated ALKS 2680 in patients with narcolepsy type 2 and idiopathic hypersomnia, showing improved wakefulness compared to … [Read more...]
Wearable Devices Can Now Harvest Our Brain Data. Australia Needs Urgent Privacy Reforms
By Edward Musole, University of New England Recent trends show Australians are increasingly buying wearables such as smartwatches and fitness trackers. These electronics track our body movements or vital signs to provide data throughout the day, with or without the help of … [Read more...]
CleveMed Launches New SleepView Data Analytics Capabilities
Summary: CleveMed has launched a software upgrade for its SleepView platform, enabling users to generate custom data analytics reports that offer enhanced insights into clinical and operational efficiency. The cloud-based module, developed in response to customer feedback, allows … [Read more...]
Fitbit Data Reveals Connections Between Sleep and Disease
Summary: A study using data from over 6,700 Fitbit users highlights the impact of sleep duration, quality, and consistency on various health outcomes. Conducted by researchers at Vanderbilt University Medical Center, the National Institute of Health’s All of Us Research Program, … [Read more...]
Vyvo’s New BioSense Ring Rewards Users for Health Data
Summary: A new wearable device, the BioSense Ring, has been introduced, combining advanced health monitoring with blockchain technology. This device offers comprehensive wellness insights and rewards users for sharing their health data while ensuring privacy and ownership. Key … [Read more...]
AI Tool Uses Apple Watch Data to Create Doctor-Reviewed Health Plans
Summary: Empirical Health’s Empirical 2.0 platform uses AI to analyze biometric data from Apple Watch, creating personalized health plans. These plans are reviewed by doctors to ensure accuracy and safety, integrating features such as advanced AI-generated care protocols, support … [Read more...]
Enrollment Opens for Hypersomnia Data Collection Initiative
Summary: Global Genes’ RARE-X platform and the Sleep Consortium have launched the Sleep Data Collection Initiative, now open for enrollment. This initiative aims to gather and share patient-owned data on central disorders of hypersomnolence, such as narcolepsy and idiopathic … [Read more...]
Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment | Sleep Review
Summary: Alkermes plc introduced plans to present 3 posters at Rest 2024, showcasing the probable positive aspects of its investigational orexin 2 receptor agonist, ALKS 2680, for narcolepsy therapy. Displays will consist of information from a period 1b research, the layout of … [Read more...]